Laxai Pharma Ltd (LAXAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 12,050 | 12,130 | 14,630 | 16,670 | 16,013 |
| Cost of Goods | 7,680 | 7,920 | 8,730 | 10,380 | N/A |
| Gross Profit | 4,360 | 4,200 | 5,900 | 6,290 | 16,013 |
| Operating Expenses | 4,950 | 5,570 | 6,340 | 7,390 | 0 |
| Operating Income | 100 | -440 | 290 | -720 | 16,013 |
| Other Income | 0 | 30 | -140 | 980 | 0 |
| Pre-tax Income | 100 | -410 | 150 | 260 | 16,013 |
| Income Tax | 0 | 0 | 30 | 0 | N/A |
| Net Income Continuous | 276 | 350 | 13 | 468 | -2,463 |
| Net Income | $270 | $-350 | $10 | $460 | $-3,013 |
| EPS Basic Total Ops | 0.04 | 0.05 | 0.00 | 0.06 | -0.50 |
| EPS Basic Continuous Ops | 0.04 | 0.05 | 0.00 | 0.06 | -0.41 |
| EPS Diluted Total Ops | 0.04 | 0.05 | 0.00 | 0.06 | -0.50 |
| EPS Diluted Continuous Ops | 0.04 | 0.05 | 0.00 | 0.06 | -0.41 |
| EBITDA(a) | $470 | $60 | $290 | $-720 | $16,013 |